Further vitamin D analogs.

Area of Science:

• Endocrinology
• Pharmacology
• Biochemistry

Background:

• Vitamin D has widespread therapeutic potential due to its specific receptor in most tissues.
• Pharmacologic increases in natural vitamin D metabolites risk significant side effects.
• Modifications to vitamin D aim for tissue selectivity to mitigate risks.

Purpose of the Study:

• To review the specificities of the vitamin D system and how molecular modifications impact biologic effects.
• To discuss the rationale behind altering different parts of the vitamin D molecule.
• To highlight the need for rigorous validation of novel vitamin D analogs.

Main Methods:

• Review of scientific literature on vitamin D analogs and their modifications.
• Analysis of structure-activity relationships of vitamin D analogs.
• Discussion of clinical applications and validation processes for vitamin D analogs.

Main Results:

• Modifications in the side chain, A-ring, or CD ring alter vitamin D's interaction with transport proteins, catabolic enzymes, and the vitamin D receptor (VDR).
• Each molecular change affects shape, influencing interactions and making biologic effects less predictable.
• Thousands of analogs exist, but only a minority are clinically approved, necessitating extensive evaluation.

Conclusions:

• Vitamin D analogs offer potential beyond osteoporosis and secondary hyperparathyroidism, including in cancer and autoimmune diseases.
• Developing selective vitamin D analogs requires understanding complex molecular interactions and thorough preclinical and clinical validation.
• Careful chemical modification and comprehensive testing are crucial for realizing the therapeutic promise of vitamin D analogs.